Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Cancer Investigation
|
March 1, 2023
Grade 4 Neutropenia Frequency as a Binary Risk Predictor for Adverse Clinical Consequences of Chemotherapy‑Induced Neutropenia: A Meta-analysis
Ramon Mohanlal, Stephan Ogenstad, Gary H Lyman, et al.
Journal of Biopharmaceutical Statistics
|
July 9, 2008
Clinical trials simulation: a statistical approach
Peter H Westfall, Kuenhi Tsai, Stephan Ogenstad, et al.
Frontiers in Physiology
|
November 7, 2017
Oral Supplementation with Baker's Yeast Beta Glucan Is Associated with Altered Monocytes, T Cells and Cytokines following a Bout of Strenuous Exercise
Brian K McFarlin, Adam S Venable, Katie C Carpenter, et al.
JAMA Network Open
|
January 27, 2022
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial
Douglas W Blayney, Ramon Mohanlal, Hryhoriy Adamchuk, et al.
JAMA Oncology
|
September 24, 2020
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial
Douglas W Blayney, Qingyuan Zhang, Jifeng Feng, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Cancer Investigation
|
March 1, 2023
Grade 4 Neutropenia Frequency as a Binary Risk Predictor for Adverse Clinical Consequences of Chemotherapy‑Induced Neutropenia: A Meta-analysis
Ramon Mohanlal, Stephan Ogenstad, Gary H Lyman, et al.
Journal of Biopharmaceutical Statistics
|
July 9, 2008
Clinical trials simulation: a statistical approach
Peter H Westfall, Kuenhi Tsai, Stephan Ogenstad, et al.
Frontiers in Physiology
|
November 7, 2017
Oral Supplementation with Baker's Yeast Beta Glucan Is Associated with Altered Monocytes, T Cells and Cytokines following a Bout of Strenuous Exercise
Brian K McFarlin, Adam S Venable, Katie C Carpenter, et al.
JAMA Network Open
|
January 27, 2022
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial
Douglas W Blayney, Ramon Mohanlal, Hryhoriy Adamchuk, et al.
JAMA Oncology
|
September 24, 2020
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial
Douglas W Blayney, Qingyuan Zhang, Jifeng Feng, et al.
Page
of 1